Collaborate Disseminate
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, with AstraZeneca revealing “encouraging data” out of its Phase I study of its obesity and diabetes drug AZD5004.Continue ReadingC… Continue reading Weight-loss pill passes important safety trial
Rapid weight loss can cause a greater loss of muscle mass than losing weight slowly. The popularity of newer weight-loss drugs that shed pounds quickly has raised concerns among researchers about how this will affect the health of our muscles, which do… Continue reading Popular weight-loss drugs cause wastage in vital skeletal muscle
The race is on to develop the first daily weight-loss pill that would be both cheaper and less invasive than the current injectable drugs on the market, with the latest strong trial results from US company Terns following similarly positive outcomes fr… Continue reading Cheaper, highly effective oral ‘Ozempic’ drugs are on the way
People living with diabetes might have a new hope. Scientists have tested a new drug therapy in diabetic mice, and found that it boosted insulin-producing cells by 700% over three months, effectively reversing their disease.Continue ReadingCategory: Me… Continue reading Diabetes-reversing drug boosts insulin-producing cells by 700%
Next-gen anti-obesity drugs like injectable liraglutide, sold as Saxenda, deliver impressive results in the first 12 months. New research looks into what happens to those results once treatment stops.Continue ReadingCategory: Health & Wellbeing, Li… Continue reading What happens when you go off weight-loss drugs?
In yet another surprise attribute of the new class of obesity drugs, scientists have found that GLP-1 receptor agonists can also subdue brain inflammation, giving them a potential ‘superpower’ in the fight against Alzheimer’s and Parkinson’s diseases.
Tags: University of Toronto, Ozempic, GLP1, Alzheimer’s Disease, Parkinson’s Disease, Inflammatory, Brain, Dementia
Continue reading GLP-1 weight-loss drugs may pivot to treat Alzheimer’s and Parkinson’s